Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
A decrease in body weight, blood pressure, HbA1c, fasting insulin, insulin resistance, plasma glucagon, total cholesterol, lipids, FPG, SMBG, cardiovascular death, nonfatal stroke, and myocardial infarction are observed with the use of semaglutide in monotherapy or in combination with other antidiabetic drugs
GLP-1 drugs for weight loss: alternatives to diabetes drugs While semaglutide, tirzepatide, and liraglutide are indicated for type 2 diabetes under the brand names Ozempic, Mounjaro, and Victoza, respectively, the active ingredients in these drugs are now available under different brand names for different indications
All medications may have potential risks and side effects
Abdominal pain: 20% of patients
US$ 26.73
US$ 20.69
US$ 25.74
US$ 28.43
US$ 28.90
US$ 20.89
US$ 25.24
